Cyberhaven launches Agentic AI Security to enhance AI governance and security for enterprises.
Mar 24, 2026
La JollaManufacturingBiotechnologyHealthcareHardwareFinancial ServicesFinanceFintechLendingBanking
Product Description
Cyberhaven has introduced Agentic AI Security to help security teams govern AI systems operating on endpoints, addressing concerns over the rise of shadow agents. This solution provides visibility, observability, and control for enterprises dealing with rapidly adopted AI agents.
Company Information
Company
Ensysce Biosciences
Location
7946 IVANHOE AVE
La Jolla, California, United States
About
Ensysce Biosciences, Inc. (NASDAQ: ENSC) is a clinical-stage biotech company developing a new class of prescription drugs that will provide patients and prescribers safer options for the use of potent prescription drugs, reducing abuse and preventing overdoses.
Fundz sees it the moment Ensysce Biosciences ships something new, hires an exec or expands, usually minutes after it happens, and tells you who to reach.